A detailed history of Exome Asset Management LLC transactions in Natera, Inc. stock. As of the latest transaction made, Exome Asset Management LLC holds 22,450 shares of NTRA stock, worth $3.63 Million. This represents 1.96% of its overall portfolio holdings.

Number of Shares
22,450
Previous 18,650 20.38%
Holding current value
$3.63 Million
Previous $2.02 Billion 41.12%
% of portfolio
1.96%
Previous 1.8%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$97.75 - $129.67 $371,450 - $492,745
3,800 Added 20.38%
22,450 $2.85 Billion
Q4 2023

Feb 14, 2024

BUY
$37.55 - $62.64 $700,307 - $1.17 Million
18,650 New
18,650 $1.17 Billion

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Exome Asset Management LLC Portfolio

Follow Exome Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exome Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exome Asset Management LLC with notifications on news.